Liver Cancer Awareness Month 2025: Insights from BMC Series Journals

Observed each October, Liver Cancer Awareness Month, aims to increase understanding of liver cancer - the third leading cause of cancer deaths globally - and to promote prevention, early detection, and improved care for all. Poster image credit: ©Chinnapong/Getty Images/iStock
Liver Cancer Awareness Month 2025: Insights from BMC Series Journals
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Liver Cancer Awareness Month is celebrated each year in October to create public awareness about liver cancer, its symptoms, risk factors, and prevention methods. According to the World Health Organization (WHO), liver cancer ranks among the top three causes of cancer-related deaths globally, responsible for more than 800,000 deaths each year. This year’s campaign “Liver Cancer Doesn’t Discriminate,” serves as a reminder that liver cancer can affect anyone, regardless of age, gender, or background and highlights the importance of liver health in everyday life.  

In this blog, we spotlight recent publications from the BMC Series journals, including BMC Cancer, BMC Gastroenterology, and BMC Psychiatry, that explore how metabolism, lifestyle, and mental wellbeing influence the occurrence and recurrence of liver cancer. 


BMC CancerBasal metabolic rate shapes the development and progression of hepatocellular carcinoma 

Hepatocellular carcinoma (HCC) is one of the most common types of primary liver cancer. A study published in BMC Cancer explores how the basal metabolic rate (BMR) influences the development and progression of HCC. Using a customized animal model, the researchers compared two lines of laboratory mice divergently selected for BMR. When liver cancer was chemically induced, the high-BMR mice developed tumors faster, showed greater disease progression, and had larger, more active livers than their low-BMR group.  

©vectornation /Getty Images/iStock

The study suggests that a genetically determined high BMR may put extra stress on liver cells, activating certain metabolism-related genes that can drive tumor formation. It also highlights how biological factors, such as genetics, and environmental, such as diet and nutrient intake shape cancer risks. The study further reinforces the importance of maintaining metabolic health through balanced nutrition, exercise, and routine check-ups, to reduce the risk of liver cancer.


BMC GastroenterologyLiver cancer risk and changes in lifestyle habits after successful hepatitis C virus therapy post-DAA) 

Hepatitis C virus (HCV) infection is the leading cause of chronic liver disease, fibrosis, and cirrhosis conditions that can eventually lead to hepatocellular carcinoma. The introduction of direct-acting antiviral (DAA) therapy has revolutionized treatment by curing most cases of HCV. However, a recent study published in BMC Gastroenterology reveals that post-cure lifestyle habits can affect long-term outcomes.  

©stockdevil/Getty Images/iStock

In this questionnaire-based study, researchers assessed individuals who had been cured of HCV using DAA combinations to understand how their daily habits changed post-treatment. Participants who become more relaxed about their health and shifted to unhealthy habits such as alcohol consumption, gained weight, and had a sedentary lifestyle were observed having slightly increased risk of liver-related complications, even after the virus was cleared.  

The authors emphasized the importance of lifestyle counseling and regular monitoring for these patients after HCV treatment. The prevalence of obesity and low physical activity among the cohort also highlights the need for targeted prevention strategies. This study highlights that liver health requires lifelong care. Staying active, eating well, avoiding alcohol, and attending follow-ups are essential for preventing disease recurrence. 


 

BMC PsychiatryChronic stress impacts the prognosis of hepatocellular carcinoma patients after curative treatment by establishing a novel comprehensive classification: a cohort study and systematic review 

Cancer patients often experience chronic stress as they navigate diagnosis and treatment, leading to insomnia, anxiety, and emotional strain. A recent study published in BMC Psychiatry explored how chronic stress affects survival outcomes in patients who had undergone curative treatment for HCC.  

©Julia Galuzinskaya/Getty Images/iStock

The researchers developed an innovative Chronic Stress Index (CSI) combining three measures - hair cortisol concentration (a biomarker of long-term stress), a Stress Score derived from physiological readings, and the Perceived Stress Scale (PSS-10) questionnaire. Using this index, they categorized patients based on their stress levels and compared disease-free survival (DFS) and overall survival (OS). The results showed that patients with higher CSI scores had significantly shorter DFS and OS compared to those with lower stress levels. Chronic stress weakens the body’s immune system, disrupts hormone balance, and promotes inflammation - all of which can lead to cancer recurrence. 

By recognizing stress as a clinical factor, healthcare professionals can provide personalized psychological support, helping patients strengthen both their physical and emotional recovery. This study shows that caring for emotional wellbeing through counseling, mindfulness, and community support can profoundly enhance recovery and quality of life for cancer patients. 


Reflections and the Road Ahead 

The evidence from recent studies published in BMC Series journals reinforces a powerful message: liver health is a lifelong responsibility. Understanding how our body functions is vital for prevention; maintaining healthy habits demands daily commitment; and caring for mental wellbeing is part of medical care. Strengthening awareness, early detection, and emotional support can help reduce the burden of liver cancer and promote collective wellbeing. 

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Liver Cancer
Life Sciences > Health Sciences > Clinical Medicine > Diseases > Gastrointestinal Diseases > Liver Diseases > Liver Cancer
Cancer Prevention
Life Sciences > Biological Sciences > Cancer Biology > Cancer Prevention
Gastrointestinal Cancer
Life Sciences > Biological Sciences > Cancer Biology > Cancers > Gastrointestinal Cancer
Hepatology
Life Sciences > Health Sciences > Clinical Medicine > Gastroenterology > Hepatology
Oncology
Life Sciences > Health Sciences > Clinical Medicine > Oncology
Lifestyle Modification
Life Sciences > Health Sciences > Public Health > Health Promotion and Disease Prevention > Disease Prevention > Lifestyle Modification
  • BMC Psychiatry BMC Psychiatry

    This is an open access, peer-reviewed journal that encompasses a wide range of topics, including psychopharmacology, psychotherapy, and psychosocial approaches to psychiatric disorders, as well as genetics, pathophysiology, and epidemiology research.

  • BMC Gastroenterology BMC Gastroenterology

    This is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of gastrointestinal and hepatobiliary disorders, as well as related molecular genetics, pathophysiology, and epidemiology.

  • BMC Cancer BMC Cancer

    This is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers.

Related Collections

With Collections, you can get published faster and increase your visibility.

Liver cirrhosis and its complications - Part II

Liver cirrhosis is a consequence of chronic liver diseases with a high morbidity and mortality. It is the 11th most common cause of death worldwide. Liver cirrhosis related complications, such as ascites, variceal bleeding, hepatic encephalopathy, jaundice, and hepatocellular carcinoma herald the progression of liver diseases.

In recent years, the management of liver cirrhosis and its complications has greatly evolved. However, prognosis is still dismal, and liver transplantation remains the sole curative treatment option.

This Collection collates original research articles and review articles regarding the management of liver cirrhosis and its complications. We were also interested in high-quality systematic reviews and meta-analyses in this field.

Topics include but are not limited to the following:

Management of compensated liver cirrhosis

Current and future therapies for cirrhosis associated portal hypertension

Management of upper gastrointestinal bleeding, ascites, hepatic encephalopathy, hepatic hydrothorax, hypersplenism, hepatic myelopathy, cirrhotic cardiomyopathy, infection, acute kidney injury, malnutrition, and portal vein thrombosis in liver cirrhosis

Use of liver support devices and extracorporeal therapies in advanced cirrhosis

Use of direct antiviral drugs, statins, anticoagulants, non-selective beta-blockers, human albumin infusions, and endoscopic variceal treatment in liver cirrhosis

Early use of transjugular intrahepatic portosystemic shunt (TIPS) in severe complications of liver cirrhosis

Early assessment of renal function, cardiac function, and nutritional status in liver cirrhosis

Role of gut microbiota in cirrhosis and associated clinical events

Pathogenesis, prognosis, and management of acute-on-chronic liver failure (ACLF)

Risk factors and surveillance for hepatocellular carcinoma in liver cirrhosis

Primary and secondary prophylaxis of gastroesophageal variceal bleeding

Impact of spontaneous portosystemic shunts (SPSS) on patients’ outcomes and its management in liver cirrhosis

Management of liver transplantation candidates and recipients

Short- and long-term prognosis of liver cirrhosis

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

Publishing Model: Open Access

Deadline: Aug 19, 2026

Artificial intelligence in gastrointestinal diagnostics

The integration of artificial intelligence (AI) into gastrointestinal diagnostics is a step toward enhancing the accuracy and efficiency of disease detection and management. By leveraging machine learning algorithms and advanced computational techniques, researchers and clinicians are able to analyze complex datasets, including imaging and pathology results. This Collection aims to explore the applications of AI in the field of gastroenterology, focusing on its potential to improve diagnostic outcomes and patient care.

The significance of AI in gastrointestinal diagnostics is underscored by recent developments in early cancer detection and the management of gastrointestinal diseases. AI-driven tools have demonstrated the capability to assist in identifying abnormalities in endoscopic images, predicting disease progression, and personalizing treatment strategies. Continued research in this area could pave the way for incremental developments, such as real-time AI-assisted diagnostic tools that improve clinician decision-making and patient care. Future research may include the refinement of AI algorithms for more accurate risk stratification, comprehensive assessments, and the establishment of robust AI frameworks that ensure ethical and equitable access to advanced diagnostic technologies.

Topics of interest include, but are not limited to:

  • AI applications in endoscopic imaging
  • Machine learning for early cancer detection
  • Pathology and AI integration
  • AI-driven diagnostics in gastrointestinal diseases
  • Predictive analytics for disease progression in gastroenterology
  • Natural language processing in clinical documentation and diagnosis
  • AI-enhanced decision support systems for clinicians
  • The role of AI in patient monitoring and management
  • Ethical considerations in AI implementation in gastroenterology

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

Publishing Model: Open Access

Deadline: Oct 14, 2026